Friday 28 June 2019

Hemophilia A Gene Therapy, SB-525, Still Showing Benefits in Early Data from Clinical Trial - Hemophilia News Today

Hemophilia A Gene Therapy, SB-525, Still Showing Benefits in Early Data from Clinical Trial  Hemophilia News Today

The ongoing Phase 1/2 Alta trial continues to show that a single infusion of SB-525, an investigational gene therapy, leads to stable and clinically relevant ...

No comments:

Post a Comment